Abstract
Background
Methods
Results
Notes
Funding
This work was supported by the Korea Medical Device Development Fund grant funded by the government of Republic of Korea (in particular, the Ministry of Science and ICT; the Ministry of Trade, Industry and Energy; the Ministry of Health and Welfare; and the Ministry of Food and Drug Safety) (Project Number: 202011823).
Conflicts of Interest
Ji-Hyun Lee has been an editor for the Korean Journal of Anesthesiology since 2021. However, she was not involved in any process of review for this article, including peer reviewer selection, evaluation, or decision-making. There were no other potential conflicts of interest relevant to this article.
Data Availability
Data will be shared with other investigators through academically established means, an necessary and appropriate. On reasonable request, the dataset from this study can be provided by the principal investigator.
Author Contributions
Pyoyoon Kang (Conceptualization; Data curation; Formal analysis; Investigation; Methodology; Software; Writing – original draft; Writing – review & editing)
Jung-bin Park (Data curation; Formal analysis; Software; Writing – original draft)
Hyun-Kyu Yoon (Data curation; Formal analysis; Investigation; Methodology; Software)
Sang-Hwan Ji (Formal analysis; Investigation; Software; Supervision; Validation)
Young-Eun Jang (Data curation; Software; Writing – review & editing)
Eun-Hee Kim (Conceptualization; Methodology; Validation; Writing – review & editing)
Ji-Hyun Lee (Conceptualization; Methodology; Writing – review & editing)
Hyung Chul Lee (Data curation; Formal analysis; Investigation; Writing – review & editing)
Jin-Tae Kim (Conceptualization; Writing – review & editing)
Hee-Soo Kim (Conceptualization; Funding acquisition; Software; Supervision; Writing – review & editing)
References
Table 1.
Values are presented as mean ± SD, number (%), or median (Q1, Q3). AKI: acute kidney injury, BMI: body mass index, ASA: American Society of Anesthesiology physical status classification system, HTN: hypertension, DM: diabetes mellitus, GOT: glutamic oxaloacetic transaminase, GPT: glutamic pyruvic transaminase, BUN: blood urea nitrogen, TIVA: total intravenous anesthesia, MBP: mean blood pressure, HR: heart rate, PPI: peripheral perfusion index. *Effect measures are odds ratio in categorical data and mean difference in continuous data. †Heart disease include ischemic heart disease, valvular heart disease, and congestive heart failure. ‡Renal disease include grade 3 or higher chronic kidney disease with or without renal replacement therapy.
Table 2.
Table 3.
PPI: peripheral perfusion index, AKI: acute kidney injury, OR: odds ratio, ASA PS: American Society of Anesthesiology physical status classification, BMI: body mass index, HTN: hypertension, DM: diabetes mellitus, TIVA: total intravenous anesthesia, MBP: mean blood pressure. *Heart diseases include ischemic heart disease, valvular heart disease, and congestive heart failure. †Renal disease includes grade 3 or higher chronic kidney disease with or without renal replacement therapy.
Table 4.
PPI: peripheral perfusion index, AKI: acute kidney injury, OR: odds ratio, ASA PS: American Society of Anesthesiology physical status classification, BMI: body mass index, HTN: hypertension, DM: diabetes mellitus, TIVA: total intravenous anesthesia, MBP: mean blood pressure. *Heart disease include ischemic heart disease, valvular heart disease, and congestive heart failure. †Renal disease include grade 3 or higher chronic kidney disease with or without renal replacement therapy.